IL85239A0 - Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it - Google Patents
Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing itInfo
- Publication number
- IL85239A0 IL85239A0 IL85239A IL8523988A IL85239A0 IL 85239 A0 IL85239 A0 IL 85239A0 IL 85239 A IL85239 A IL 85239A IL 8523988 A IL8523988 A IL 8523988A IL 85239 A0 IL85239 A0 IL 85239A0
- Authority
- IL
- Israel
- Prior art keywords
- purification
- production
- pharmaceutical compositions
- compositions containing
- surfactant protein
- Prior art date
Links
- 239000003580 lung surfactant Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US845387A | 1987-01-29 | 1987-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL85239A0 true IL85239A0 (en) | 1988-07-31 |
Family
ID=21731690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL85239A IL85239A0 (en) | 1987-01-29 | 1988-01-28 | Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU1294888A (en) |
| IL (1) | IL85239A0 (en) |
| WO (1) | WO1988005820A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258496A (en) * | 1990-07-10 | 1993-11-02 | Scios Nova Inc. | Isolation and purification of lung surfactant protein |
| US6031075A (en) * | 1996-02-05 | 2000-02-29 | Children's Hospital Medical Center | Mature alveolar SP-B and a process for producing the same |
| ATE269101T1 (en) * | 1999-01-19 | 2004-07-15 | Altana Pharma Ag | RECOMBINANT SP-A FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS AND INFLAMMATIONS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4506013A (en) * | 1980-10-03 | 1985-03-19 | Eli Lilly And Company | Stabilizing and selecting recombinant DNA host cells |
| US4562003A (en) * | 1984-10-26 | 1985-12-31 | California Biotechnology, Inc. | Monoclonal antibodies against alveolar surfactant protein |
| US4659805A (en) * | 1984-12-11 | 1987-04-21 | California Biotechnology, Inc. | Recombinant alveolar surfactant protein |
-
1988
- 1988-01-15 WO PCT/US1988/000092 patent/WO1988005820A1/en not_active Ceased
- 1988-01-15 AU AU12948/88A patent/AU1294888A/en not_active Abandoned
- 1988-01-28 IL IL85239A patent/IL85239A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1988005820A1 (en) | 1988-08-11 |
| AU1294888A (en) | 1988-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2204792B (en) | Pharmaceutical composition | |
| ZA883167B (en) | Pharmaceutical composition | |
| ZA878176B (en) | Substituted alpha-amino acids,their preparation and pharmaceutical compositions containing them | |
| GB8810765D0 (en) | Pharmaceutical composition | |
| HUT58107A (en) | Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins | |
| EG18652A (en) | Pharmaceutical compositions | |
| GB8804697D0 (en) | Pharmaceutical compositions | |
| IL91003A0 (en) | Proteins,their production and pharmaceutical compositions containing them | |
| IL85239A0 (en) | Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it | |
| IL91002A0 (en) | Modified proteins,their production and pharmaceutical compositions containing them | |
| GB8713091D0 (en) | Pharmaceutical compositions | |
| IL82780A0 (en) | Peptides,their manufacture and pharmaceutical compositions containing them | |
| GB2206115B (en) | 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| IE871109L (en) | Recombinant alveolar surfactant protein | |
| GB8728689D0 (en) | Amino acid pharmaceutical compositions | |
| SG135393G (en) | 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| GB8708041D0 (en) | Pharmaceutical composition | |
| IE872168L (en) | Pharmaceutical composition | |
| GB8716574D0 (en) | Pharmaceutical composition | |
| ZA881474B (en) | Pharmaceutical composition | |
| GB8718907D0 (en) | Pharmaceutical composition | |
| ZA883400B (en) | Pharmaceutical composition | |
| GB8725055D0 (en) | Pharmaceutical composition | |
| GB8725648D0 (en) | Pharmaceutical composition | |
| GB8705900D0 (en) | Pharmaceutical composition |